eccogene glp-1 AZD5004 AstraZeneca licenses Eccogene's oral GLP-1

This study demonstrates that a three-month treatment with methylcobalamin and folinic acid is associated with significant improvements in behavioral symptoms associated with autism spectrum disorder in a group of children with autistic disorder and metabolic markers of abnormal redox and methylation metabolism

Reductions of glycemic index and hyperinsulinemia by GLP-1 GLP-1 exerts an important effect directly on the brain, and this effect is probably even more important for the analogues than for the endogenous GLP-1 released after ingestion of protein and fat

For psyllium, this means one full standard dose (3.4 grams) once daily

Peptide therapy is not a quick fix and should be combined with a healthy diet and regular exercise for optimal results